NASDAQ:IMPV - Imperva Stock Price, Price Target & More

$49.35 0.00 (0.00 %)
(As of 04/22/2018 10:03 AM ET)
Previous Close$49.35
Today's Range$48.10 - $49.75
52-Week Range$37.17 - $52.40
Volume469,225 shs
Average Volume311,292 shs
Market Capitalization$1.72 billion
P/E Ratio-176.25
Dividend YieldN/A
Beta1.67

About Imperva (NASDAQ:IMPV)

Imperva logoImperva, Inc. engages in the development, market, sale, and support of cyber security solutions that protect business critical data and applications in the cloud or on premises worldwide. The company's SecureSphere product line provides database, file, and Web application security in various data centers, including on-premises data centers, as well as in private, public, and hybrid cloud computing environments. Its SecureSphere product also secures business-critical applications and data; and provides an accelerated route to address regulatory compliance and establishes a repeatable process for data risk management. The company's Incapsula service delivers cloud-based Website security, distributed denial of service protection, and load balancing and failover; and is designed to deploy and accessible to businesses that need to optimize the security, speed, and availability of their Websites. Its products also include ThreatRadar that provides reputation and crowdsourced security intelligence services; CounterBreach, which protects enterprise data from theft and loss due to compromised, malicious, and careless users; and Imperva Camouflage Data Masking that creates functional data for development, testing, and training by disguising sensitive information while maintaining the characteristics of the original data. In addition, the company provides ongoing product support services for hardware and software; and professional and training services. Imperva, Inc. offers its products and services to banks, retailers, insurers, technology and telecommunication companies, and hospitals; and the United States and other national, state, and local government agencies through a network of distributors and resellers. The company was founded in 2002 and is headquartered in Redwood Shores, California.

Receive IMPV News and Ratings via Email

Sign-up to receive the latest news and ratings for IMPV and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Prepackaged software
Sub-IndustrySystems Software
SectorComputer and Technology
SymbolNASDAQ:IMPV
CUSIP45321L10
Phone650-345-9000

Debt

Debt-to-Equity RatioN/A
Current Ratio2.71%
Quick Ratio2.70%

Price-To-Earnings

Trailing P/E Ratio-176.25
Forward P/E Ratio1,645.00
P/E Growth56.4

Sales & Book Value

Annual Sales$321.72 million
Price / Sales5.34
Cash Flow$0.0559 per share
Price / Cash882.54
Book Value$9.26 per share
Price / Book5.33

Profitability

EPS (Most Recent Fiscal Year)($0.28)
Net Income$22.86 million
Net Margins7.11%
Return on Equity-3.28%
Return on Assets-1.94%

Miscellaneous

Employees1,020
Outstanding Shares34,810,000

How to Become a New Pot Stock Millionaire

Imperva (NASDAQ:IMPV) Frequently Asked Questions

What is Imperva's stock symbol?

Imperva trades on the NASDAQ under the ticker symbol "IMPV."

How were Imperva's earnings last quarter?

Imperva (NASDAQ:IMPV) announced its quarterly earnings data on Thursday, February, 8th. The software maker reported $0.40 earnings per share for the quarter, beating the Zacks' consensus estimate of $0.27 by $0.13. The software maker had revenue of $91.10 million for the quarter, compared to analyst estimates of $91.11 million. Imperva had a negative return on equity of 3.28% and a net margin of 7.11%. The firm's revenue for the quarter was up 16.2% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.32 EPS. View Imperva's Earnings History.

When is Imperva's next earnings date?

Imperva is scheduled to release their next quarterly earnings announcement on Thursday, April, 26th 2018. View Earnings Estimates for Imperva.

What price target have analysts set for IMPV?

16 brokerages have issued 12-month price objectives for Imperva's stock. Their forecasts range from $39.00 to $61.00. On average, they anticipate Imperva's share price to reach $53.2308 in the next twelve months. View Analyst Ratings for Imperva.

What are Wall Street analysts saying about Imperva stock?

Here are some recent quotes from research analysts about Imperva stock:
  • 1. According to Zacks Investment Research, "Imperva Inc. is engaged in the development of protection software and services for business applications and databases. The Company delivers innovative technology to give full audit accountability and separation of duties to meet regulatory compliance. It offers SecureSphere Data Security Suite to protect sensitive data from hackers and malicious insiders along with providing a fast and cost-effective route to regulatory compliance and establishes a repeatable process for data risk management. The Company's SecureSphere offers database security solutions to secure sensitive data stored in databases, File Security solutions to protect sensitive files on file servers, storage devices, content repositories, and meet regulatory compliance mandates and Web Application Security solutions to protect web applications from cyber attacks. Imperva Inc. is headquartered in Redwood Shores, California. " (4/11/2018)
  • 2. Evercore ISI analysts commented, "We believe that the quarter was in part helped by the deposition of Skyfence which carried annual operating expenses of ~$25M (and revenue of ~$1M). There is likely a tailwind to margins in 2Q from the deposition as well, despite the company’s ongoing plans to reinvest the savings in growth areas. Management guided to ~7% non-GAAP margins for F17 which compares favorably to consensus of ~5.6% going into the quarter. We continue to believe that the company is working to improve its business but has largely overcome the execution challenges that plagued results last year. We are encouraged by the high level of growth (+64.5% y/y in 1Q17) seen in the company’s subscription offerings which may be further helped by the introduction of FlexProtect which makes form factor (on-prem vs cloud) less relevant. This should offset concerns on the company’s on-premise WAF decline." (5/5/2017)

Are investors shorting Imperva?

Imperva saw a increase in short interest in March. As of March 15th, there was short interest totalling 1,847,957 shares, an increase of 56.0% from the February 28th total of 1,184,332 shares. Based on an average daily volume of 540,724 shares, the short-interest ratio is presently 3.4 days. Currently, 5.4% of the shares of the stock are sold short.

Who are some of Imperva's key competitors?

Who are Imperva's key executives?

Imperva's management team includes the folowing people:
  • Ms. Trâm T. Phi, Sr. VP, Gen. Counsel & Corp. Sec. (Age 47)
  • Mr. Christopher S. Hylen, Pres, CEO & Director (Age 57)
  • Mr. Michael J. Burns, Chief Financial Officer & Treasurer (Age 52)
  • Mr. Aharon Strosberg, VP of Operations
  • Mr. Terry Ray, Chief Technology Officer

Has Imperva been receiving favorable news coverage?

News headlines about IMPV stock have been trending somewhat positive recently, according to Accern Sentiment Analysis. The research firm identifies negative and positive media coverage by reviewing more than 20 million news and blog sources. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. Imperva earned a news impact score of 0.20 on Accern's scale. They also assigned news articles about the software maker an impact score of 45.38 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the company's share price in the next few days.

How do I buy shares of Imperva?

Shares of IMPV can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Imperva's stock price today?

One share of IMPV stock can currently be purchased for approximately $49.35.

How big of a company is Imperva?

Imperva has a market capitalization of $1.72 billion and generates $321.72 million in revenue each year. The software maker earns $22.86 million in net income (profit) each year or ($0.28) on an earnings per share basis. Imperva employs 1,020 workers across the globe.

How can I contact Imperva?

Imperva's mailing address is 3400 BRIDGE PARKWAY SUITE 200, REDWOOD SHORES CA, 94065. The software maker can be reached via phone at 650-345-9000 or via email at [email protected]


MarketBeat Community Rating for Imperva (IMPV)

Community Ranking:  3.3 out of 5 (star star star)
Outperform Votes:  577 (Vote Outperform)
Underperform Votes:  299 (Vote Underperform)
Total Votes:  876
MarketBeat's community ratings are surveys of what our community members think about Imperva and other stocks. Vote "Outperform" if you believe IMPV will outperform the S&P 500 over the long term. Vote "Underperform" if you believe IMPV will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Imperva (NASDAQ:IMPV) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
16 Wall Street analysts have issued ratings and price targets for Imperva in the last 12 months. Their average twelve-month price target is $53.2308, suggesting that the stock has a possible upside of 7.86%. The high price target for IMPV is $61.00 and the low price target for IMPV is $39.00. There are currently 2 sell ratings, 4 hold ratings and 10 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyHoldHoldBuy
Consensus Rating Score: 2.502.472.412.58
Ratings Breakdown: 2 Sell Rating(s)
4 Hold Rating(s)
10 Buy Rating(s)
0 Strong Buy Rating(s)
2 Sell Rating(s)
4 Hold Rating(s)
9 Buy Rating(s)
0 Strong Buy Rating(s)
2 Sell Rating(s)
6 Hold Rating(s)
9 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
8 Hold Rating(s)
11 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $53.2308$53.00$52.00$51.3214
Price Target Upside: 7.86% upside13.86% upside24.25% upside17.98% upside

Imperva (NASDAQ:IMPV) Consensus Price Target History

Price Target History for Imperva (NASDAQ:IMPV)

Imperva (NASDAQ:IMPV) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
4/10/2018DA DavidsonInitiated CoverageBuy -> Buy$56.00HighView Rating Details
2/9/2018Imperial CapitalBoost Price TargetOutperform -> Outperform$50.00 -> $55.00LowView Rating Details
2/9/2018Morgan StanleyBoost Price TargetUnderweight -> Underweight$37.00 -> $39.00HighView Rating Details
2/9/2018Evercore ISISet Price TargetBuy$56.00HighView Rating Details
2/9/2018Piper JaffrayUpgradeNeutral -> Overweight$52.00HighView Rating Details
12/12/2017JPMorgan ChaseDowngradeNeutral -> Underweight$45.00HighView Rating Details
11/9/2017OppenheimerReiterated RatingBuy$55.00N/AView Rating Details
11/9/2017Stifel NicolausReiterated RatingHold -> Hold$50.00 -> $47.00N/AView Rating Details
10/24/2017KeyCorpReiterated RatingHoldN/AView Rating Details
10/18/2017Royal Bank of CanadaReiterated RatingBuy$49.00N/AView Rating Details
10/10/2017William BlairDowngradeOutperform -> Market PerformN/AView Rating Details
10/9/2017Wells FargoDowngradeOutperform -> Market PerformN/AView Rating Details
7/28/2017Monness Crespi & HardtBoost Price TargetBuy$55.00 -> $57.00HighView Rating Details
7/13/2017StephensReiterated RatingOverweight$53.00 -> $61.00LowView Rating Details
6/7/2017Susquehanna BancsharesInitiated CoveragePositive -> Positive$60.00LowView Rating Details
6/6/2017UBSInitiated CoveragePositive$60.00N/AView Rating Details
2/9/2017BTIG ResearchInitiated CoverageNeutralN/AView Rating Details
11/4/2016NomuraReiterated RatingHold$37.50N/AView Rating Details
11/4/2016Needham & Company LLCUpgradeHold -> Buy$64.00 -> $43.00N/AView Rating Details
11/4/2016MacquarieUpgradeNeutral -> OutperformN/AView Rating Details
10/22/2016Buckingham ResearchReiterated RatingNeutral$45.00N/AView Rating Details
10/15/2016Deutsche BankReiterated RatingHoldN/AView Rating Details
9/25/2016JMP SecuritiesReiterated RatingOutperform$50.00 -> $56.00N/AView Rating Details
9/13/2016WunderlichInitiated CoverageHold$50.00N/AView Rating Details
8/30/2016Pacific CrestDowngradeOverweight -> Sector Weight$47.00 -> $30.00N/AView Rating Details
(Data available from 4/22/2016 forward)

Earnings

Imperva (NASDAQ:IMPV) Earnings History and Estimates Chart

Earnings by Quarter for Imperva (NASDAQ:IMPV)

Imperva (NASDAQ:IMPV) Earnings Estimates

2018 EPS Consensus Estimate: ($1.61)
2019 EPS Consensus Estimate: $0.63
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20181($0.60)($0.60)($0.60)
Q2 20181($0.51)($0.51)($0.51)
Q3 20181($0.50)($0.50)($0.50)
Q1 20191$0.02$0.02$0.02
Q2 20191$0.10$0.10$0.10
Q3 20191$0.19$0.19$0.19
Q4 20191$0.32$0.32$0.32

Imperva (NASDAQ IMPV) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/2/2018$0.13N/AView Earnings Details
2/8/2018Q4 2017$0.27$0.40$91.11 million$91.10 millionViewListenView Earnings Details
11/8/2017Q3 2017$0.22$0.33$83.79 million$83.89 millionViewN/AView Earnings Details
7/27/2017Q2 2017$0.05($0.10)$74.30 million$74.44 millionViewN/AView Earnings Details
5/4/2017Q1 2017($0.62)($0.29)$68.16 million$72.31 millionViewListenView Earnings Details
2/8/2017Q416$0.03$0.32$70.22 million$78.40 millionViewListenView Earnings Details
11/3/2016Q316($0.16)$0.08$63.10 million$68.40 millionViewListenView Earnings Details
8/4/2016Q216($0.04)($0.23)$66.06 million$57.87 millionViewListenView Earnings Details
5/5/2016Q116($0.28)($0.25)$59.65 million$59.80 millionViewListenView Earnings Details
2/3/2016Q415$0.15$0.20$68.11 million$72.70 millionViewListenView Earnings Details
10/29/2015Q3($0.05)$0.19$56.52 million$63.30 millionViewListenView Earnings Details
8/6/2015Q215($0.21)($0.08)$48.40 million$53.50 millionViewListenView Earnings Details
5/7/2015Q115($0.38)($0.26)$40.50 million$44.80 millionViewListenView Earnings Details
2/5/2015Q414($0.04)($0.04)$49.80 million$51.40 millionViewListenView Earnings Details
10/30/2014Q314($0.63)($0.51)$40.00 million$42.70 millionViewListenView Earnings Details
7/31/2014Q2 2014($0.72)($0.59)$38.44 millionViewN/AView Earnings Details
5/1/2014Q114($0.41)($0.36)$31.73 million$31.50 millionViewListenView Earnings Details
2/6/2014Q413$0.11$0.12$41.63 million$42.70 millionViewListenView Earnings Details
11/5/2013Q313($0.05)($0.01)$34.43 million$35.10 millionViewListenView Earnings Details
8/7/2013Q2 2013($0.05)($0.10)$31.38 million$31.30 millionViewListenView Earnings Details
5/2/2013Q1 2013($0.10)($0.13)$27.49 million$28.60 millionViewListenView Earnings Details
2/7/2013Q4 2012$0.02$0.06$29.91 million$31.80 millionViewListenView Earnings Details
11/1/2012Q3 2012($0.07)($0.08)ViewN/AView Earnings Details
8/9/2012($0.05)($0.02)ViewN/AView Earnings Details
5/3/2012($0.13)($0.12)ViewN/AView Earnings Details
2/9/2012($0.15)($0.05)ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

Imperva (NASDAQ:IMPV) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Imperva (NASDAQ IMPV) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 1.10%
Insider Trading History for Imperva (NASDAQ:IMPV)
Insider Trading History for Imperva (NASDAQ:IMPV)

Imperva (NASDAQ IMPV) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
2/20/2018Anthony J BettencourtDirectorSell66,037$46.98$3,102,418.2666,037View SEC Filing  
2/20/2018Michael D MooneyCROSell24,454$47.18$1,153,739.7224,454View SEC Filing  
8/24/2017Anthony J BettencourtDirectorSell99,598$43.59$4,341,476.8299,598View SEC Filing  
5/16/2017Sunil D NagdevSVPSell4,857$49.00$237,993.0016,290View SEC Filing  
5/15/2017Amichai ShulmanInsiderSell3,089$48.70$150,434.30100,151View SEC Filing  
5/10/2017Michael D MooneyCROSell52,356$47.51$2,487,433.5652,356View SEC Filing  
4/17/2017Amichai ShulmanInsiderSell3,085$41.97$129,477.4599,151View SEC Filing  
3/15/2017Amichai ShulmanInsiderSell3,085$41.85$129,107.2599,151View SEC Filing  
2/28/2017Mark E KraynakSVPSell45,314$41.63$1,886,421.8210,064View SEC Filing  
2/21/2017Anthony J BettencourtChairmanSell84,863$45.55$3,865,509.6584,863View SEC Filing  
2/21/2017Terrence J SchmidCFOSell4,500$45.53$204,885.00432View SEC Filing  
2/16/2017Mark E KraynakSVPSell1,731$46.10$79,799.103,858View SEC Filing  
2/15/2017Amichai ShulmanInsiderSell3,085$45.91$141,632.3595,713View SEC Filing  
1/17/2017Amichai ShulmanCTOSell3,085$40.60$125,251.00View SEC Filing  
12/21/2016Amichai ShulmanInsiderSell3,085$40.00$123,400.0091,830View SEC Filing  
11/16/2016Mark E KraynakSVPSell3,332$40.16$133,813.12448View SEC Filing  
11/15/2016Amichai ShulmanInsiderSell3,085$40.10$123,708.5092,000View SEC Filing  
10/17/2016Amichai ShulmanInsiderSell3,085$48.57$149,838.4591,062View SEC Filing  
10/3/2016Amichai ShulmanInsiderSell938$53.27$49,967.2695,085View SEC Filing  
9/23/2016Amichai ShulmanInsiderSell937$51.00$47,787.0095,084View SEC Filing  
9/23/2016Mark E. KraynakSVPSell5,582$51.00$284,682.00View SEC Filing  
9/15/2016Amichai ShulmanInsiderSell3,085$44.30$136,665.5094,147View SEC Filing  
8/16/2016Mark E KraynakSVPSell2,614$47.73$124,766.223,552View SEC Filing  
8/15/2016Amichai ShulmanInsiderSell3,085$46.87$144,593.9594,317View SEC Filing  
7/27/2016Amichai ShulmanInsiderSell3,085$46.28$142,773.8093,380View SEC Filing  
7/26/2016Mark E KraynakSVPSell2,967$46.15$136,927.052,968View SEC Filing  
6/23/2016Shlomo KramerMajor ShareholderSell75,000$45.12$3,384,000.001,304,521View SEC Filing  
6/20/2016Shlomo KramerMajor ShareholderSell75,000$40.24$3,018,000.001,304,521View SEC Filing  
5/31/2016Terrence J SchmidCFOSell5,000$37.66$188,300.00335View SEC Filing  
5/25/2016Anthony J BettencourtCEOSell50,000$36.15$1,807,500.0052,938View SEC Filing  
5/19/2016Shlomo KramerMajor ShareholderSell50,000$34.20$1,710,000.001,304,521View SEC Filing  
5/17/2016Shlomo KramerMajor ShareholderSell75,000$33.95$2,546,250.001,304,521View SEC Filing  
5/16/2016Terrence J SchmidCFOSell7,000$33.99$237,930.008,053View SEC Filing  
5/12/2016Shlomo KramerMajor ShareholderSell75,000$34.16$2,562,000.001,304,521View SEC Filing  
3/31/2016Mark E. KraynakSVPSell2,758$50.00$137,900.00View SEC Filing  
3/1/2016Amichai ShulmanCTOSell3,000$45.25$135,750.0089,527View SEC Filing  
2/24/2016Terrence J SchmidCFOSell6,500$41.82$271,830.007,468View SEC Filing  
2/17/2016Mark E KraynakSVPSell2,758$40.04$110,430.322,758View SEC Filing  
2/8/2016Albert A PimentelDirectorBuy5,000$38.93$194,650.004,475View SEC Filing  
2/8/2016Amichai ShulmanCTOSell4,150$38.12$158,198.0082,590View SEC Filing  
2/1/2016Amichai ShulmanCTOSell3,000$50.49$151,470.0086,740View SEC Filing  
1/4/2016Amichai ShulmanCTOSell5,812$60.36$350,812.3286,740View SEC Filing  
12/1/2015Amichai ShulmanCTOSell3,000$74.22$222,660.0086,740View SEC Filing  
11/19/2015Mark E. KraynakinsiderSell10,000$75.00$750,000.00View SEC Filing  
11/19/2015Tram T. PhiVPSell1,244$73.26$91,135.445,975View SEC Filing  
11/16/2015Anthony J. BettencourtCEOSell50,000$69.33$3,466,500.008,489View SEC Filing  
11/16/2015Mark E. KraynakinsiderSell3,789$68.73$260,417.97View SEC Filing  
11/12/2015Shlomo KramerMajor ShareholderSell100,000$71.65$7,165,000.001,259,521View SEC Filing  
11/6/2015Shlomo KramerMajor ShareholderSell50,000$72.14$3,607,000.001,259,521View SEC Filing  
11/4/2015Shlomo KramerMajor ShareholderSell25,000$72.05$1,801,250.001,259,521View SEC Filing  
11/4/2015Terrence J. SchmidCFOSell938$71.14$66,729.32View SEC Filing  
11/3/2015Shlomo KramerMajor ShareholderSell25,000$72.55$1,813,750.001,259,521View SEC Filing  
10/1/2015Amichai ShulmanCTOSell2,813$65.00$182,845.0084,802View SEC Filing  
8/31/2015Terrence J. SchmidCFOSell1,595$61.56$98,188.20View SEC Filing  
8/17/2015Mark E KraynakInsiderSell1,520$71.42$108,558.40View SEC Filing  
7/23/2015Amichai ShulmanCTOSell9,000$70.00$630,000.00View SEC Filing  
5/11/2015Amichai ShulmanCTOSell10,313$51.09$526,891.17View SEC Filing  
5/11/2015Mark E KraynakInsiderSell4,000$55.00$220,000.00View SEC Filing  
4/20/2015Mark E KraynakInsiderSell3,000$47.53$142,590.00View SEC Filing  
1/20/2015Mark E KraynakInsiderSell3,000$44.60$133,800.00View SEC Filing  
1/8/2015Amichai ShulmanCTOSell1,875$50.00$93,750.00View SEC Filing  
12/16/2014Amichai ShulmanCTOSell9,492$50.00$474,600.00View SEC Filing  
12/15/2014Amichai ShulmanCTOSell11,133$50.00$556,650.00View SEC Filing  
12/1/2014Amichai ShulmanCTOSell5,000$42.44$212,200.00View SEC Filing  
11/28/2014Yaniv ShayaVPSell2,512$44.00$110,528.00View SEC Filing  
11/20/2014Mark E KraynakInsiderSell6,140$42.00$257,880.00View SEC Filing  
11/14/2014Yaniv ShayaVPSell20,938$44.52$932,159.76View SEC Filing  
11/13/2014Mark E KraynakInsiderSell2,000$45.00$90,000.00View SEC Filing  
11/11/2014Tram T PhiVPSell10,076$43.50$438,306.00View SEC Filing  
11/4/2014Terrence J SchmidCFOSell20,000$40.73$814,600.00View SEC Filing  
11/3/2014Amichai ShulmanCTOSell5,000$41.09$205,450.00View SEC Filing  
10/31/2014Amichai ShulmanCTOSell7,500$36.56$274,200.00View SEC Filing  
10/31/2014Mark E KraynakInsiderSell2,000$36.56$73,120.00View SEC Filing  
10/6/2014Amichai ShulmanCTOSell2,500$30.00$75,000.00View SEC Filing  
9/2/2014Amichai ShulmanCTOSell5,000$30.00$150,000.00View SEC Filing  
8/21/2014Terrence J SchmidCFOSell15,000$29.07$436,050.00View SEC Filing  
5/23/2014Ralph PisaniVPSell8,613$21.31$183,543.03View SEC Filing  
5/21/2014Terrence SchmidCFOSell15,000$21.26$318,900.002,853View SEC Filing  
4/7/2014Shlomo KramerCEOSell60,000$50.53$3,031,800.001,229,521View SEC Filing  
4/2/2014Shlomo KramerCEOSell40,000$55.67$2,226,800.001,229,521View SEC Filing  
1/8/2014Shlomo KramerCEOSell20,000$50.10$1,002,000.001,219,521View SEC Filing  
1/7/2014Shlomo KramerCEOSell40,000$49.99$1,999,600.001,219,521View SEC Filing  
1/3/2014Shlomo KramerCEOSell40,000$48.31$1,932,400.001,219,521View SEC Filing  
1/2/2014Amichai ShulmanCTOSell22,875$47.68$1,090,680.0010,000View SEC Filing  
12/17/2013Amichai ShulmanCTOSell10,090$45.00$454,050.0010,000View SEC Filing  
12/2/2013Amichai ShulmanCTOSell12,410$44.13$547,653.3010,000View SEC Filing  
11/26/2013Yaniv ShayaVPSell5,243$43.92$230,272.565,000View SEC Filing  
11/21/2013Jason ForgetSVPSell8,558$38.98$333,590.84View SEC Filing  
11/21/2013Terrence SchmidCFOSell11,100$40.26$446,886.00View SEC Filing  
11/21/2013Tram PhiVPSell6,646$39.50$262,517.00View SEC Filing  
11/19/2013Mark KraynakVPSell3,190$37.80$120,582.0015,000View SEC Filing  
8/29/2013Yaniv ShayaVPSell4,375$48.00$210,000.00View SEC Filing  
8/26/2013Jason ForgetSVPSell2,500$47.50$118,750.00View SEC Filing  
8/26/2013Yaniv ShayaVPSell5,000$47.71$238,550.00View SEC Filing  
8/23/2013Terrence SchmidCFOSell2,539$47.20$119,840.80View SEC Filing  
8/21/2013Jason ForgetSVPSell2,500$47.00$117,500.00View SEC Filing  
8/20/2013Terrence SchmidCFOSell10,461$47.03$491,980.83View SEC Filing  
8/16/2013Jason ForgetSVPSell2,062$47.00$96,914.00View SEC Filing  
8/14/2013Tram PhiVPSell5,000$46.00$230,000.00View SEC Filing  
8/13/2013Jason ForgetSVPSell2,000$45.01$90,020.00View SEC Filing  
8/13/2013Mark KraynakVPSell10,000$44.41$444,100.0015,000View SEC Filing  
8/5/2013Amichai ShulmanCTOSell1,086$52.58$57,101.88View SEC Filing  
8/2/2013Amichai ShulmanCTOSell46,140$51.87$2,393,281.80View SEC Filing  
7/3/2013Amichai ShulmanCTOSell3,222$45.21$145,666.62View SEC Filing  
7/1/2013Amichai ShulmanCTOSell16,778$44.94$754,003.32View SEC Filing  
6/3/2013Amichai ShulmanCTOSell20,000$39.49$789,800.00View SEC Filing  
5/30/2013Amichai ShulmanCTOSell10,000$39.93$399,300.00View SEC Filing  
5/30/2013Yaniv ShayaVPSell4,375$40.40$176,750.00View SEC Filing  
5/29/2013Amichai ShulmanCTOSell20,000$39.96$799,200.00View SEC Filing  
5/28/2013Tram T PhiVPSell5,000$40.25$201,250.00View SEC Filing  
5/24/2013Yaniv ShayaVPSell2,250$40.00$90,000.00View SEC Filing  
5/14/2013Yaniv ShayaVPSell10,000$39.00$390,000.00View SEC Filing  
5/13/2013Albert A PimentelDirectorSell10,000$37.93$379,300.00View SEC Filing  
5/13/2013Ralph PisaniVPSell5,000$38.46$192,300.00View SEC Filing  
5/13/2013Terrence J SchmidCFOSell13,000$37.75$490,750.00View SEC Filing  
5/8/2013Jason ForgetSVPSell4,063$37.31$151,590.53View SEC Filing  
3/26/2013Amichai ShulmanCTOSell20,000$38.30$766,000.00View SEC Filing  
2/26/2013Amichai ShulmanCTOSell20,000$36.05$721,000.00View SEC Filing  
12/28/2012Amichai ShulmanCTOSell10,000$31.01$310,100.00View SEC Filing  
12/27/2012Amichai ShulmanCTOSell20,000$30.98$619,600.00View SEC Filing  
12/5/2012Michael BoodaeiDirectorSell30,000$31.48$944,400.00View SEC Filing  
11/27/2012Amichai ShulmanCTOSell20,000$29.06$581,200.00View SEC Filing  
11/7/2012James R TolonenDirectorBuy5,000$31.17$155,850.00View SEC Filing  
11/1/2012Amichai ShulmanCTOSell20,000$31.71$634,200.00View SEC Filing  
10/4/2012Michael BoodaeiDirectorSell30,000$34.03$1,020,900.00View SEC Filing  
9/5/2012Michael BoodaeiDirectorSell20,000$30.35$607,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Imperva (NASDAQ IMPV) News Headlines

Source:
DateHeadline
Imperva (IMPV) Downgraded by ValuEngine to SellImperva (IMPV) Downgraded by ValuEngine to Sell
www.americanbankingnews.com - April 19 at 2:58 PM
Imperva Inc (IMPV) Given Consensus Recommendation of "Hold" by BrokeragesImperva Inc (IMPV) Given Consensus Recommendation of "Hold" by Brokerages
www.americanbankingnews.com - April 18 at 7:24 PM
Imperva (IMPV) Lifted to "Buy" at BidaskClubImperva (IMPV) Lifted to "Buy" at BidaskClub
www.americanbankingnews.com - April 17 at 9:57 AM
$84.16 Million in Sales Expected for Imperva Inc (IMPV) This Quarter$84.16 Million in Sales Expected for Imperva Inc (IMPV) This Quarter
www.americanbankingnews.com - April 17 at 5:01 AM
Imperva (IMPV) Stock Rating Lowered by BidaskClubImperva (IMPV) Stock Rating Lowered by BidaskClub
www.americanbankingnews.com - April 16 at 9:48 AM
Zacks: Analysts Anticipate Imperva Inc (IMPV) Will Post Earnings of $0.19 Per ShareZacks: Analysts Anticipate Imperva Inc (IMPV) Will Post Earnings of $0.19 Per Share
www.americanbankingnews.com - April 15 at 1:17 AM
North American Database Security Market Report 2018 - Data Privacy Laws are Driving the MarketNorth American Database Security Market Report 2018 - Data Privacy Laws are Driving the Market
www.prnewswire.com - April 13 at 4:47 PM
Analysts Set Expectations for Imperva Incs Q1 2019 Earnings (IMPV)Analysts Set Expectations for Imperva Inc's Q1 2019 Earnings (IMPV)
www.americanbankingnews.com - April 13 at 9:31 AM
DA Davidson Offers 4 Reasons To Like ImpervaDA Davidson Offers 4 Reasons To Like Imperva
www.msn.com - April 12 at 9:54 AM
DA Davidson starts Imperva at 27% upsideDA Davidson starts Imperva at 27% upside
seekingalpha.com - April 12 at 9:54 AM
Imperva Appoints David Woodcock to Lead Worldwide SalesImperva Appoints David Woodcock to Lead Worldwide Sales
finance.yahoo.com - April 11 at 4:47 PM
Imperva (IMPV) Downgraded by Zacks Investment ResearchImperva (IMPV) Downgraded by Zacks Investment Research
www.americanbankingnews.com - April 11 at 9:52 AM
Evercore ISI Reiterates "$56.00" Price Target for Imperva (IMPV)Evercore ISI Reiterates "$56.00" Price Target for Imperva (IMPV)
www.americanbankingnews.com - April 10 at 8:54 PM
Imperva (IMPV) Coverage Initiated at DA DavidsonImperva (IMPV) Coverage Initiated at DA Davidson
www.americanbankingnews.com - April 10 at 5:02 PM
Imperva (IMPV) Upgraded to Hold by BidaskClubImperva (IMPV) Upgraded to Hold by BidaskClub
www.americanbankingnews.com - April 9 at 12:59 AM
Imperva (IMPV) Downgraded by William Blair to "Market Perform"Imperva (IMPV) Downgraded by William Blair to "Market Perform"
www.americanbankingnews.com - April 7 at 6:04 PM
Imperva (IMPV) PT Lowered to $50.00 at Imperial CapitalImperva (IMPV) PT Lowered to $50.00 at Imperial Capital
www.americanbankingnews.com - April 7 at 4:58 PM
Piper Jaffray Downgrades Imperva (IMPV) to NeutralPiper Jaffray Downgrades Imperva (IMPV) to Neutral
www.americanbankingnews.com - April 7 at 12:26 PM
What Are Analysts Saying About The Future Of Imperva Inc’s (NASDAQ:IMPV)?What Are Analysts Saying About The Future Of Imperva Inc’s (NASDAQ:IMPV)?
finance.yahoo.com - April 4 at 9:14 AM
Stifel Nicolaus Reaffirms Hold Rating for Imperva (IMPV)Stifel Nicolaus Reaffirms Hold Rating for Imperva (IMPV)
www.americanbankingnews.com - March 31 at 7:10 PM
Impervas (IMPV) "Underweight" Rating Reaffirmed at Morgan StanleyImperva's (IMPV) "Underweight" Rating Reaffirmed at Morgan Stanley
www.americanbankingnews.com - March 31 at 5:28 PM
Imperva Inc (IMPV) Expected to Announce Quarterly Sales of $84.18 MillionImperva Inc (IMPV) Expected to Announce Quarterly Sales of $84.18 Million
www.americanbankingnews.com - March 31 at 4:36 AM
Imperva Inc (IMPV) Short Interest UpdateImperva Inc (IMPV) Short Interest Update
www.americanbankingnews.com - March 30 at 3:38 AM
Imperva (IMPV) Rating Lowered to Hold at Zacks Investment ResearchImperva (IMPV) Rating Lowered to Hold at Zacks Investment Research
www.americanbankingnews.com - March 29 at 7:58 PM
BidaskClub Lowers Imperva (IMPV) to HoldBidaskClub Lowers Imperva (IMPV) to Hold
www.americanbankingnews.com - March 29 at 11:28 AM
$0.19 EPS Expected for Imperva Inc (IMPV) This Quarter$0.19 EPS Expected for Imperva Inc (IMPV) This Quarter
www.americanbankingnews.com - March 29 at 5:16 AM
Imperva (IMPV) Shares Cross Below 200 DMAImperva (IMPV) Shares Cross Below 200 DMA
www.nasdaq.com - March 28 at 9:20 AM
Imperva (IMPV) Stock Rating Upgraded by BidaskClubImperva (IMPV) Stock Rating Upgraded by BidaskClub
www.americanbankingnews.com - March 25 at 9:31 AM
Imperva Inc (IMPV) Given Consensus Recommendation of "Buy" by BrokeragesImperva Inc (IMPV) Given Consensus Recommendation of "Buy" by Brokerages
www.americanbankingnews.com - March 24 at 7:32 PM
4 Cyber-Security Stocks in Focus Post Expedia-Orbitz Hack4 Cyber-Security Stocks in Focus Post Expedia-Orbitz Hack
finance.yahoo.com - March 23 at 4:49 PM
Imperva Inc (IMPV) Holdings Lifted by Sei Investments Co.Imperva Inc (IMPV) Holdings Lifted by Sei Investments Co.
www.americanbankingnews.com - March 6 at 7:24 AM
Imperva (IMPV) Rating Lowered to Sell at ValuEngineImperva (IMPV) Rating Lowered to Sell at ValuEngine
www.americanbankingnews.com - March 4 at 4:28 PM
First Trust Advisors LP Has $9.24 Million Position in Imperva Inc (IMPV)First Trust Advisors LP Has $9.24 Million Position in Imperva Inc (IMPV)
www.americanbankingnews.com - March 4 at 9:50 AM
Spark Investment Management LLC Takes Position in Imperva Inc (IMPV)Spark Investment Management LLC Takes Position in Imperva Inc (IMPV)
www.americanbankingnews.com - March 2 at 12:29 PM
Imperva Inc (IMPV) Receives Consensus Recommendation of "Buy" from BrokeragesImperva Inc (IMPV) Receives Consensus Recommendation of "Buy" from Brokerages
www.americanbankingnews.com - February 27 at 9:30 PM
Carillon Tower Advisers Inc. Invests $36.80 Million in Imperva Inc (IMPV)Carillon Tower Advisers Inc. Invests $36.80 Million in Imperva Inc (IMPV)
www.americanbankingnews.com - February 27 at 5:32 AM
 Brokerages Expect Imperva Inc (IMPV) Will Post Quarterly Sales of $84.18 Million Brokerages Expect Imperva Inc (IMPV) Will Post Quarterly Sales of $84.18 Million
www.americanbankingnews.com - February 25 at 9:52 AM
Imperva Inc (IMPV) CRO Sells $1,153,739.72 in StockImperva Inc (IMPV) CRO Sells $1,153,739.72 in Stock
www.americanbankingnews.com - February 22 at 6:32 PM
Imperva Inc (IMPV) Director Anthony J. Bettencourt Sells 66,037 SharesImperva Inc (IMPV) Director Anthony J. Bettencourt Sells 66,037 Shares
www.americanbankingnews.com - February 22 at 6:14 PM
Imperva Announces Transition of Its Chairman of the BoardImperva Announces Transition of Its Chairman of the Board
finance.yahoo.com - February 21 at 4:55 PM
Imperva (IMPV) Upgraded to Hold by ValuEngineImperva (IMPV) Upgraded to Hold by ValuEngine
www.americanbankingnews.com - February 17 at 6:34 PM
Imperva (IMPV) Upgraded to "Strong-Buy" by Zacks Investment ResearchImperva (IMPV) Upgraded to "Strong-Buy" by Zacks Investment Research
www.americanbankingnews.com - February 17 at 6:00 PM
BRIEF-Elliott Reports Combined Economic Exposure Of About 6 Pct In ImpervaBRIEF-Elliott Reports Combined Economic Exposure Of About 6 Pct In Imperva
www.reuters.com - February 15 at 8:31 AM
Imperva Target of Unusually High Options Trading (IMPV)Imperva Target of Unusually High Options Trading (IMPV)
www.americanbankingnews.com - February 15 at 6:38 AM
Traders Purchase High Volume of Call Options on Imperva (IMPV)Traders Purchase High Volume of Call Options on Imperva (IMPV)
www.americanbankingnews.com - February 14 at 8:44 PM
Imperva Protects NetRefer Website and Customers From CyberattacksImperva Protects NetRefer Website and Customers From Cyberattacks
finance.yahoo.com - February 13 at 9:29 AM
Imperva (IMPV) Upgraded to "Overweight" by Piper Jaffray CompaniesImperva (IMPV) Upgraded to "Overweight" by Piper Jaffray Companies
www.americanbankingnews.com - February 10 at 10:22 PM
Evercore ISI Analysts Give Imperva (IMPV) a $56.00 Price TargetEvercore ISI Analysts Give Imperva (IMPV) a $56.00 Price Target
www.americanbankingnews.com - February 10 at 4:44 PM
Imperva (IMPV) Price Target Increased to $55.00 by Analysts at Imperial CapitalImperva (IMPV) Price Target Increased to $55.00 by Analysts at Imperial Capital
www.americanbankingnews.com - February 9 at 10:36 PM
Imperva (IMPV) Given New $39.00 Price Target at Morgan StanleyImperva (IMPV) Given New $39.00 Price Target at Morgan Stanley
www.americanbankingnews.com - February 9 at 6:42 PM

SEC Filings

Imperva (NASDAQ:IMPV) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Imperva (NASDAQ:IMPV) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Imperva (NASDAQ IMPV) Stock Chart for Sunday, April, 22, 2018

Loading chart…

This page was last updated on 4/22/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.